Hsu Jason 4
4 · Immix Biopharma, Inc. · Filed May 29, 2026
Research Summary
AI-generated summary of this filing
Immix Biopharma (IMMX) Director Jason Hsu Receives Award
What Happened
Director Jason Hsu received equity awards from Immix Biopharma on May 22, 2026: 6,250 restricted stock units (RSUs) granted at $0.00 and a 12,500-share derivative award (a stock option-type grant) reported at $0.00. These were awards/grants, not open-market purchases or sales, so no cash changed hands at grant.
Key Details
- Transaction date: 2026-05-22; Form filed: 2026-05-29 (appears later than the typical 2-business-day Form 4 deadline).
- Grants reported: 6,250 RSUs @ $0.00 (Acquired); 12,500 derivative (stock option) units @ $0.00 (Acquired).
- Shares owned after transaction: not specified on this Form 4.
- Footnotes of note:
- F1: The 6,250 RSUs vest in full on the earlier of the one-year anniversary of grant or the Issuer’s 2027 annual meeting, subject to continued service.
- F4: The 12,500-share option vests in substantially equal monthly installments over 12 months (or accelerates at the 2027 annual meeting), subject to continued board service.
- F2/F3: Hsu is sole member of two LLCs referenced (VERITAS LIBERABIT VOS, LLC and Signature Collection Properties, LLC) and disclaims beneficial ownership of securities held by those entities except to the extent of pecuniary interest.
Context
These are standard compensation awards to a director (not a purchase or sale). RSUs and option grants typically align incentives with shareholder value but do not represent immediate cash proceeds or open-market buying. The filing date is later than usual for Form 4s, which are typically due within two business days of the transaction; late filing is a reporting issue but does not, by itself, indicate trading intent.
Insider Transaction Report
- Award
Common Stock
[F1]2026-05-22+6,250→ 899,250 total - Award
Stock Option (Right to Buy)
[F4]2026-05-22+12,500→ 12,500 totalExercise: $8.78Exp: 2036-05-22→ Common Stock (12,500 underlying)
- 3,915,913(indirect: See Footnote)
Common Stock
[F2] - 50,000(indirect: See Footnote)
Common Stock
[F3]
Footnotes (4)
- [F1]The Reporting Person was granted 6,250 restricted stock units ("RSUs") pursuant to the Issuer's 2021 Equity Incentive Plan, which RSUs will vest in full on the earlier of (i) the one-year anniversary of the date of grant, and (ii) the date that the Issuer's 2027 annual meeting of stockholders (the "2027 Annual Meeting") is held, subject to the Reporting Person's continued service with the Issuer.
- [F2]The Reporting Person is the sole member of VERITAS LIBERABIT VOS, LLC and in such capacity has the right to vote and dispose of the securities held by such entity. The Reporting Person disclaims beneficial ownership of the securities held by VERITAS LIBERABIT VOS, LLC, except to the extent of his pecuniary interest therein.
- [F3]The Reporting Person is the sole member of Signature Collection Properties, LLC and in such capacity has the right to vote and dispose of the securities held by such entity. The Reporting Person disclaims beneficial ownership of the securities held by Signature Collection Properties, LLC, except to the extent of his pecuniary interest therein.
- [F4]The stock option will vest in substantially equal monthly installments over the 12 months following the date of grant (or, in the event the 2027 Annual Meeting occurs prior to the first anniversary of the date of grant, any remaining unvested portion of the stock option will vest on the date of such 2027 Annual Meeting), subject to the Reporting Person's continued service on the Issuer's Board through the applicable vesting date.